These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 9007151)
1. Esterase inhibitors diminish the modulation of gene expression by butyric acid derivative, pivaloyloxymethyl butyrate (AN-9). Rabizadeh E; Shaklai M; Eisenbach L; Nudelman A; Rephaeli A Isr J Med Sci; 1996 Dec; 32(12):1186-91. PubMed ID: 9007151 [TBL] [Abstract][Full Text] [Related]
2. Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line. Aviram A; Zimrah Y; Shaklai M; Nudelman A; Rephaeli A Int J Cancer; 1994 Mar; 56(6):906-9. PubMed ID: 8119779 [TBL] [Abstract][Full Text] [Related]
3. The role of intracellularly released formaldehyde and butyric acid in the anticancer activity of acyloxyalkyl esters. Nudelman A; Levovich I; Cutts SM; Phillips DR; Rephaeli A J Med Chem; 2005 Feb; 48(4):1042-54. PubMed ID: 15715472 [TBL] [Abstract][Full Text] [Related]
4. Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells. Aviram A; Rephaeli A; Shaklai M; Nudelman A; Ben-Dror I; Maron L; Rabizadeh E J Cancer Res Clin Oncol; 1997; 123(5):267-71. PubMed ID: 9201249 [TBL] [Abstract][Full Text] [Related]
5. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy. Chen ZX; Breitman TR Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972 [TBL] [Abstract][Full Text] [Related]
6. Rapid alteration of c-myc and c-jun expression in leukemic cells induced to differentiate by a butyric acid prodrug. Rabizadeh E; Shaklai M; Nudelman A; Eisenbach L; Rephaeli A FEBS Lett; 1993 Aug; 328(3):225-9. PubMed ID: 8348968 [TBL] [Abstract][Full Text] [Related]
7. Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis. Zimra Y; Nudelman A; Zhuk R; Rabizadeh E; Shaklai M; Aviram A; Rephaeli A J Cancer Res Clin Oncol; 2000 Dec; 126(12):693-8. PubMed ID: 11153141 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Herold KM; Rothberg PG Oncogene; 1988 Oct; 3(4):423-8. PubMed ID: 3078950 [TBL] [Abstract][Full Text] [Related]
9. Changes in Hox1.6, c-jun, and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction. Iwai SA; Kosaka M; Nishina Y; Sumi T; Sakuda M; Nishimune Y Exp Cell Res; 1993 Mar; 205(1):39-43. PubMed ID: 8453995 [TBL] [Abstract][Full Text] [Related]
10. Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells. Zimra Y; Wasserman L; Maron L; Shaklai M; Nudelman A; Rephaeli A J Cancer Res Clin Oncol; 1997; 123(3):152-60. PubMed ID: 9119880 [TBL] [Abstract][Full Text] [Related]
11. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Litvak DA; Evers BM; Hwang KO; Hellmich MR; Ko TC; Townsend CM Surgery; 1998 Aug; 124(2):161-9; discussion 169-70. PubMed ID: 9706134 [TBL] [Abstract][Full Text] [Related]
12. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells. Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016 [TBL] [Abstract][Full Text] [Related]
13. Modulation of heat-shock protein 70 (HSP70) gene expression by sodium butyrate in U-937 promonocytic cells: relationships with differentiation and apoptosis. Garcia-Bermejo L; Vilaboa NE; Perez C; Galan A; De Blas E; Aller P Exp Cell Res; 1997 Oct; 236(1):268-74. PubMed ID: 9344607 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of 17 structural analogues of n-butyric acid upon c-myc expression. Rottleb C; Hall C; Bornkamm GW; Polack A Int J Cancer; 1996 Sep; 67(5):724-9. PubMed ID: 8782665 [TBL] [Abstract][Full Text] [Related]
15. A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies. Patnaik A; Rowinsky EK; Villalona MA; Hammond LA; Britten CD; Siu LL; Goetz A; Felton SA; Burton S; Valone FH; Eckhardt SG Clin Cancer Res; 2002 Jul; 8(7):2142-8. PubMed ID: 12114414 [TBL] [Abstract][Full Text] [Related]
16. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells]. Chuĭkin IA; Lianguzova MS; Pospelov VA Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838 [TBL] [Abstract][Full Text] [Related]
17. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells. Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. Tsai LC; Hung MW; Chang GG; Chang TC Anticancer Res; 2000; 20(4):2441-8. PubMed ID: 10953308 [TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells. Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251 [TBL] [Abstract][Full Text] [Related]
20. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Wilson AJ; Velcich A; Arango D; Kurland AR; Shenoy SM; Pezo RC; Levsky JM; Singer RH; Augenlicht LH Cancer Res; 2002 Nov; 62(21):6006-10. PubMed ID: 12414619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]